Сonferences Eureka Science

11.09.20131747
It is our great pleasure to announce the latest editions of our very successful series of conferences; the “6th International Conference on Drug Discovery and Therapy” and the “3rd Biotechnology World Congress” in Dubai UAE.

Program Improves Blood Pressure Control

10.09.20131444
A large-scale program for controlling high blood pressure in a California health care system could help pave the way for improving blood pressure control in the general population.

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data

09.09.20131417
Cangrelor is a potent, rapid-acting, reversible intravenous platelet inhibitor that was tested for percutaneous coronary intervention (PCI) in three large, double-blind, randomised trials.

Impact of obesity on response to thienopyridine and bleeding risk in patients treated after acute coronary syndrome by clopidogrel or prasugrel

06.09.20131544
Variability of response to thienopyridine has been described for both clopidogrel and prasugrel.

Reduced kidney function and anemia as risk factors for new onset AF

05.09.20131604
Each of chronic kidney disease (CKD) and anemia is a potential independent risk factor for cardiovascular disease (CVD); however, reduced kidney function, anemia, and its relationship have not been fully evaluated for the incidence of atrial fibrillation (AF).

Gender Data Forum: Are DES Safer and More Effective Than Bare Metal Stents in Women?

04.09.20131356
The use of drug-eluting stents (DES) in women is more effective and safe than using bare-metal stents during long-term follow-up, according to a study released on Sept. 2 during the ESC Congress 2013 and simultaneously published in The Lancet.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.